Sialic Acid Binding Molecules for Lung Inflammation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for lung inflammatory diseases, such as pneumonia and bronchitis, face challenges due to antibiotic resistance and the need for alternative medicaments that effectively address inflammation caused by viral, bacterial, fungal infections, and other inflammatory conditions.
Innovation Solution
Development of sialic acid binding molecules that bind to sialic acid on cell surfaces, inhibiting cytokine responses and cell influx, thereby reducing inflammation and tissue damage in the lungs, which can be administered via mucosal or inhalation routes for prophylactic and therapeutic use.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional antibiotic treatments are used for lung inflammatory diseases, then bacterial infections can be treated, but antibiotic resistance develops reducing treatment effectiveness
Solution Approach 1:
The patent introduces sialic acid binding molecules as intermediary substances that mediate the treatment of lung inflammatory diseases. These molecules bind to sialic acid on cell surfaces and inhibit cytokine responses, serving as an alternative mechanism that does not rely on antibiotics, thereby avoiding antibiotic resistance while maintaining treatment effectiveness
Solution Approach 2:
The patent changes the treatment parameter from antibiotic-based therapy to sialic acid binding molecule therapy. By targeting a different biological pathway (cytokine response inhibition rather than bacterial killing), the treatment maintains effectiveness against lung inflammation without contributing to antibiotic resistance
2Object-affected harmful factors
If sialic acid binding molecules are administered to inhibit cytokine responses, then inflammation and tissue damage are reduced, but the mechanism of action differs from conventional infection treatment
Solution Approach 1:
The patent extracts and targets the specific mechanism of inflammation and tissue damage caused by cytokine responses. By focusing on inhibiting this specific harmful pathway rather than treating the entire infection process, the treatment reduces inflammation and tissue damage through a targeted mechanism that, while different from conventional approaches, is biologically straightforward
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The sialic acid binding molecules effectively suppress cytokine responses and cell migration, reducing inflammatory responses and associated damage, providing a novel approach for treating and preventing lung inflammatory diseases, including pneumonia, bronchitis, and other conditions like COPD and asthma.
Implementation Method 1
molecules with affinity for (or an ability to bind to) sialic acid (and in particular sialoglycoconjugates) on cell surfaces
Data Source
AI summary
Disclosed are molecules with affinity for (or an ability to bind to) sialic acid (and in particular sialoglycoconjugates) on cell surfaces (these including sialic acid containing glycoproteins and cell surface sialic acid receptors), for use in treating or preventing of inflammatory diseases and/or conditions with an inflammatory aeitiology. The disclosed molecules may be of particular use in the treatment and/or prevention of diseases and/or conditions characterised by inflammation occurring as a consequence of a cascade of cytokines, inflammation that may occur in and around the tissues and/or structures of the lung and inflammation occurring as a result of an infection.